MedTrace Logo

Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome Syndrome

NCT07576114 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-08

No results posted yet for this study

Summary

The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.

Conditions

  • Syndrome

Interventions

OTHER

Group B: Gluteal Muscle Activation and Core stregthening exercises

Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.Core Strengthening focuses on stabilizing the spine and pelvis by targeting the abdominals, back, and deep pelvic muscles.

OTHER

Group A: Gluteal Muscle Activation

Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Attiq Ur Rehman, MS · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-05
Primary Completion
2026-05-05
Completion
2026-05-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576114 on ClinicalTrials.gov